Cranial placodes are embryonic structures essential for sensory and endocrine organ development. The efficient derivation of cranial placodes from human pluripotent stem cells is disclosed where the timed removal of the BMP inhibitor Noggin, a component of the dual-SMAD inhibition strategy of neural induction, triggers placode induction at the expense of CNS fates. Further fate specification at the pre-placode stage enables the selective generation of placode-derived trigeminal ganglia capable of in vivo engraftment, mature lens fibers and anterior pituitary hormone-producing cells that upon transplantation produce hormones including, but not limited to, human growth hormone and adrenocortiocotropic hormone in vivo. Alternatively, anterior pituitary hormone-producing cells are generated in cell culture systems in vitro.

Cranial placodes are embryonic structures essential for sensory and endocrine organ development. The efficient derivation of cranial placodes from human pluripotent stem cells is disclosed where the timed removal of the BMP inhibitor Noggin, a component of the dual-SMAD inhibition strategy of neural induction, triggers placode induction at the expense of CNS fates. Further fate specification at the pre-placode stage enables the selective generation of placode-derived trigeminal ganglia capable of in vivo engraftment, mature lens fibers and anterior pituitary hormone-producing cells that upon transplantation produce hormones including, but not limited to, human growth hormone and adrenocortiocotropic hormone in vivo. Alternatively, anterior pituitary hormone-producing cells are generated in cell culture systems in vitro.

The present invention relates to a compound as represented by formula (I). The present invention also provides compositions and formulations containing such compounds, and methods for using and preparing such compounds.

##STR00001##

A shielding cover and a display device are provided. The shielding cover includes: a shielding cover body; and a shielding cover accessory fixedly connected to the shielding cover body. The shielding cover accessory includes: an accessory bottom including a flat bottom; a connecting arm through which the shielding cover accessory is connected to the shielding cover body; and a positioning arm. The connecting arm and the positioning arm are connected to two opposite ends of the accessory bottom, and protrude in opposite directions from the accessory bottom. The shielding cover accessory further includes a plurality of card slots arranged at positions of the flat bottom close to the positioning arm, each card slot penetrates the flat bottom in a direction perpendicular to the flat bottom, and the plurality of card slots are arranged at intervals in a direction parallel to an extending direction of the positioning arm.

Cranial placodes are embryonic structures essential for sensory and endocrine organ development. The efficient derivation of cranial placodes from human pluripotent stem cells is disclosed where the timed removal of the BMP inhibitor Noggin, a component of the dual-SMAD inhibition strategy of neural induction, triggers placode induction at the expense of CNS fates. Further fate specification at the pre-placode stage enables the selective generation of placode-derived trigeminal ganglia capable of in vivo engraftment, mature lens fibers and anterior pituitary hormone-producing cells that upon transplantation produce hormones including, but not limited to, human growth hormone and adrenocortiocotropic hormone in vivo. Alternatively, anterior pituitary hormone-producing cells are generated in cell culture systems in vitro.

Cranial placodes are embryonic structures essential for sensory and endocrine organ development. The efficient derivation of cranial placodes from human pluripotent stem cells is disclosed where the timed removal of the BMP inhibitor Noggin, a component of the dual-SMAD inhibition strategy of neural induction, triggers placode induction at the expense of CNS fates. Further fate specification at the pre-placode stage enables the selective generation of placode-derived trigeminal ganglia capable of in vivo engraftment, mature lens fibers and anterior pituitary hormone-producing cells that upon transplantation produce hormones including, but not limited to, human growth hormone and adrenocortiocotropic hormone in vivo. Alternatively, anterior pituitary hormone-producing cells are generated in cell culture systems in vitro.

A shielding cover and a display device are provided. The shielding cover includes: a shielding cover body; and a shielding cover accessory fixedly connected to the shielding cover body. The shielding cover accessory includes: an accessory bottom including a flat bottom; a connecting arm through which the shielding cover accessory is connected to the shielding cover body; and a positioning arm. The connecting arm and the positioning arm are connected to two opposite ends of the accessory bottom, and protrude in opposite directions from the accessory bottom. The shielding cover accessory further includes a plurality of card slots arranged at positions of the flat bottom close to the positioning arm, each card slot penetrates the flat bottom in a direction perpendicular to the flat bottom, and the plurality of card slots are arranged at intervals in a direction parallel to an extending direction of the positioning arm.